{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:08:42Z","timestamp":1758931722177,"version":"3.44.0"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>Persistent shortages of essential medicines in the United States, especially generic oncology drugs, continue to compromise timely cancer care and patient safety. The presence of multiple high-level reports from federal agencies and industry experts has outlined similar recommendations, including the creation of a unified essential medicines list, transparent supply chain monitoring, domestic manufacturing incentives, and centralized federal coordination, among others, giving an optimistic direction. This manuscript synthesizes key findings from these reports and highlights misalignment across agency roles and priorities as a barrier to sustained progress. Case studies of cisplatin, vincristine, and methotrexate shortages underscore the high stakes of inaction. Drawing on recent coordination successes during the COVID-19 response, we propose a practical path forward: establishing a central federal coordinating body, legislating an essential medicines list developed using an established criticality-reach-vulnerability framework, reforming procurement incentives, and expanding the Strategic National Stockpile.<\/jats:p>","DOI":"10.1097\/ppo.0000000000000787","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T13:00:15Z","timestamp":1758891615000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Advancing Federal Coordination to Address Drug Shortages"],"prefix":"10.1097","volume":"31","author":[{"given":"Emeka E.","family":"Duru","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwame","family":"Kissi-Twum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenechukwu C.","family":"Ben-Umeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7786-5780","authenticated-orcid":false,"given":"T. Joseph","family":"Mattingly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,9]]},"reference":[{"key":"R3-20250926","doi-asserted-by":"crossref","first-page":"e0215837","DOI":"10.1371\/journal.pone.0215837","article-title":"The impacts of medication shortages on patient outcomes: a scoping review","volume":"14","author":"Phuong","year":"2019","journal-title":"PLoS One"},{"key":"R4-20250926","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/cpt.1934","article-title":"The drug shortage era: a scoping review of the literature 2001-2019","volume":"108","author":"Tucker","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"R6-20250926","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S1470-2045(23)00289-9","article-title":"Cancer care critically affected by USA drug shortages","volume":"24","author":"Gourd","year":"2023","journal-title":"Lancet Oncol"},{"key":"R7-20250926","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1634\/theoncologist.2019-1010","article-title":"Drug shortages: the view across an ocean","volume":"25","author":"Shuman","year":"2020","journal-title":"Oncologist"},{"key":"R9-20250926","first-page":"170","article-title":"Economic and technological drivers of generic sterile injectable drug shortages","volume":"93","author":"Woodcock","year":"2013","journal-title":"Clin Pharmacol Ther"},{"key":"R11-20250926","first-page":"573","article-title":"Ensuring a high-quality and resilient supply chain of essential medications means paying more","volume":"28","author":"Mattingly","year":"2022","journal-title":"J Manag Care Spec Pharm"},{"key":"R12-20250926","doi-asserted-by":"crossref","first-page":"e224824","DOI":"10.1001\/jamahealthforum.2022.4824","article-title":"Should the administration for strategic preparedness and response lead the national response to a public health emergency?","volume":"4","author":"Adashi","year":"2023","journal-title":"JAMA Health Forum"},{"key":"R16-20250926","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/scipol\/scae020","article-title":"Operation warp speed: harbinger of American industrial innovation policies","volume":"51","author":"Bonvillian","year":"2024","journal-title":"Sci Public Policy"},{"key":"R17-20250926","doi-asserted-by":"crossref","first-page":"816","DOI":"10.2146\/ajhp180048","article-title":"Drug shortages roundtable: minimizing the impact on patient care","volume":"75","year":"2018","journal-title":"Am J Health Syst Pharm"},{"key":"R18-20250926","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10669-018-9691-8","article-title":"A capabilities approach to the prioritization of critical infrastructure","volume":"38","author":"Clark","year":"2018","journal-title":"Environ Syst Decis"},{"key":"R25-20250926","first-page":"oyad323","article-title":"Methotrexate scarcity among children\u2019s oncology group institutions: results of a multinational survey","author":"Menig","year":"2023","journal-title":"Oncologist"},{"key":"R26-20250926","first-page":"264","article-title":"Lessons from the leucovorin shortages between 2009 and 2012 in a medicare advantage population: where do we go from here?","volume":"7","author":"Hayes","year":"2014","journal-title":"Am Health Drug Benefits"},{"key":"R27-20250926","first-page":"1","article-title":"Vincristine shortage spurs pediatric oncologists to push reform ideas","volume":"25","author":"Lienhard","year":"2019","journal-title":"Inside Health Pol"}],"container-title":["The Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PPO.0000000000000787","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T13:00:17Z","timestamp":1758891617000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PPO.0000000000000787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":13,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ppo.0000000000000787","relation":{},"ISSN":["1540-336X"],"issn-type":[{"value":"1540-336X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"2025-06-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}